Trial
NCT03900754
A Pharmaco-imaging Approach to Predicting Social Functioning and Clinical Responses to Oxytocin Administration in Schizophrenia
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
VA Office of Research and Development
Collaborators
University of California, San Francisco; VA Greater Los Angeles Healthcare System
Condition
Schizophrenia
Intervention
Oxytocin
Why stopped
Inadequate Subject Recruitment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-01-20